Ex-Teva Scientist Testifies In Copaxone Patent Battle

By Christie Smythe · July 11, 2011, 6:39 PM EDT

A former Teva Pharmaceutical Industries Ltd. scientist testified Monday in New York that the company uncovered safety concerns as it was developing multiple sclerosis drug Copaxone, necessitating patents that generics makers...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Christie

July 28, 2011
Ex-Hospital Admins Face 2 Trials In Kickbacks Case
July 26, 2011
US Airs Disgraced Pol's Calls In Hospital Bribe Trial
July 08, 2011
Alleged Gangster Cops Plea In $100M Medicare Fraud Case
June 27, 2011
New Charges Coming In Hospital Bribery Case, Feds Say
April 29, 2011
Ex-Hospital Exec Gets Bench Trial In Bribery Case
April 14, 2011
UBS Urges 2nd Circ. To Nix Hospital Co.'s ARS Win
April 13, 2011
Feds Charge FrontPoint Trader In $30M Inside Tips Case
March 18, 2011
Convicted Trader Protests SEC Penalty In 2nd Circ.
February 15, 2011
Quigley To Meet Deadline Or Face Asbestos Claims
December 23, 2010
SEC Sues InterMune Options Buyers Over Inside Tips